Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Jul 9.
Published in final edited form as: J Am Chem Soc. 2010 Jun 16;132(23):7830–7831. doi: 10.1021/ja100220x

Non-Innocent Dithiolene Ligands: A New Oxomolybdenum Complex Possessing a Donor-Acceptor Dithiolene Ligand

Kelly G Matz 1, Regina P Mtei 2, Belinda Leung 1, Sharon J Nieter Burgmayer 1,*, Martin L Kirk 2,*
PMCID: PMC3132408  NIHMSID: NIHMS309146  PMID: 20481628

Abstract

A new monoanionic dithiolene ligand is found in Tp*MoO(S2BMOQO). A combination of x-ray crystallography, electronic absorption and resonance Raman spectroscopies, and bonding calculations reveal that the monoanionic dithiolene ligand possesses considerable thiolate-thione character resulting from admixture of an intraligand charge transfer excited state into the ground state wavefunction. The unusual dithiolene exhibits a highly versatile donor-acceptor character that dramatically lowers the Mo(IV/V) redox couple and points to a potentially non-innocent role of the pterin fragment in pyranopterin Mo enzymes.

graphic file with name nihms309146f6.jpg


Systems that display rich metal-ligand redox interplay14 and possess intraligand donor-acceptor interactions57 have captured the attention of the chemical community due to their importance in enzymatic catalysis2, 8, 9 and molecular electronics.1012 Dithiolene ligands facilitate complex redox chemistry1, 8 and have been used as key components of donor-acceptor molecules.13, 14 The pyranopterin molybdenum enzymes possess a redox active Mo center bound by at least one pyranopterin dithiolene ligand (Fig. 1) and catalyze a variety of two-electron redox reactions coupled to the formal transfer of an oxo atom between the active site and substrate.15, 16 Although it is widely accepted that Mo-based redox processes dominate in the catalytic cycle of the enzymes,15 both the dithiolene chelate and the pyranopterin contribute further redox possibilities through their highly non-innocent redox nature.8 Reduced dithiolenes can be oxidized by one electron to a radical form,17 or by two electrons to yield dithione or dithiete resonance forms.1 Additionally, the pyranopterin can potentially store up to four redox equivalents via a combination of pyran ring opening and two-electron oxidation of the pterin ring.8, 18 Thus, the Mo-pyranopterin-dithiolene ensemble is one of the most redox non-innocent structures in biology. Here we provide structural and spectroscopic evidence supporting a highly unusual electronic structure in Tp*MoO(S2BMOQO) (1) (Fig. 2) that provides added insight into the complex electron and atom transfer reactivity in this interesting class of metalloenzymes.

Figure 1.

Figure 1

The pyranopterin dithiolene ligand bound to the active site molybdenum as the reduced dianionic dithiolene.

Figure 2.

Figure 2

Synthetic path to compounds 1, 2, and 3: (a) acetonitrile, 70°; (b) PPh3, silica gel; (c) [Fe(C5H5)2][PF6].

The synthesis of 1 is part of a larger study19 directed toward synthesizing small molecule analogues that possess pterin- and quinoxaline-substituted dithiolenes. The dithiolene ligand in 1 is generated in a coupling reaction of a quinoxalyl alkyne with a molybdenum tetrasulfide (Fig. 2a). This reaction initially yields the molybdenum sulfido compound 2 that hydrolyzes to 1 (Fig. 2b). 1 exhibits sharp 1H NMR resonances consistent with a diamagnetic d2 Mo(4+) center, in marked contrast to the structurally related pentavalent oxomolybdenum dithiolene complex, Tp*Mo5+O(qdt) (qdt = quinoxaline-2,3-dithiolate).20 The cyclic voltammagram of 1 displays a reversible couple at + 0.250 V (vs. Ag/AgCl in ACN; Fc+/Fc +0.400 V) assigned to Mo(5+)/Mo(4+) reduction. This reduction potential is shifted 300 mV more positive than that observed for Tp*MoO(qdt), underscoring the highly electron withdrawing nature of this dithiolene and indicating a markedly more stabilized Mo(4+) state. Ferrocenium oxidation of 1 yields the EPR active species 3 (Fig. 2c) that possesses typical Mo hyperfine structure confirming that 3 is a d1 Mo(V) species and not a ligand radical. Compound 1 is not EPR active and displays no paramagnetically shifted NMR resonances. Thus, the oxidation state of 1 is most consistent with a low-spin d2 Mo(IV) species.

The X-ray structure of 1 (Fig. 3) provides key evidence for an unusual electronic structure that derives from the nature of the quinoxalyl-dithiolene ligand. A striking aspect of the structure that points to a remarkable electronic asymmetry within the MoS2C2 dithiolene chelate ring is that the Mo-S2 distance is 0.04 Å longer than Mo-S1 while S2-C2 is 0.05Å shorter than S1-C1, indicating some degree of thiol/thione character in 1. Additionally, an average dithiolene fold angle of 13.3 deg is observed within the Mo-S1-S2-C1-C2 atoms of the dithiolene chelate.

Figure 3.

Figure 3

ORTEP drawing of one molecule of 1 with 30% probability thermal ellipsoids. Selected bond distances (Å): Mo1-S1 2.4164(14), Mo1-S2 2.4565(14), Mo1-O1 1.688(3), S1-C1 1.748(5)-S2-C2 1.695(5), N1-C11 1.357(7).

Compound 1 is deep blue with an intense absorption at 16,400 cm−1 (ε=5,190 M−1cm−1) (Fig. 4). Interestingly, intense low-energy charge transfer (CT) transitions are not observed in Tp*Mo5+O(qdt)20, 21 and are not anticipated for Tp*Mo4+O(dithiolene) complexes due to the low-spin (xy)2 electronic configuration that precludes one-electron promotions to the Mo(xy) redox orbital. To our knowledge, intense low-energy CT features have never been observed in a Tp*MoO(dithiolene) complex, and therefore the presence of the 16,400 cm−1 band supports a novel electronic structure for 1. Resonance Raman (rR) spectroscopy has identified a number of high frequency quinoxaline vibrational modes in 1 that are strongly resonantly enhanced with excitation into the 16,400 cm−1 CT band, and excitation profiles for the 1345 and 1551 cm−1 vibrations are presented in Fig. 4. The intensity of Band 2 and the dominant resonance enhancement of both quinoxaline and C=C modes are consistent with an electron withdrawing quinoxaline fragment that acts as an acceptor in the 16,400 cm−1 transition. The rR and absorption data are consistent with the results of bonding and excited state calculations, allowing us to assign Band 2 as an intraligand dithiolene(S)→quinoxaline CT transition (HOMO-1→LUMO) possessing a small degree of MLCT character. The assignment of Band 2 allows the lower energy transition (Band 1) (9,763 cm−1, ε = 250 M−1cm−1) to be assigned as a Mo(xy)→quinoxaline (HOMO→LUMO) MLCT transition, in line with the acceptor nature of the quinoxaline fragment.

Figure 4.

Figure 4

Gaussian resolved electron absorption spectrum of 1 in acetonitrile, and solid state rR excitation profiles. These vibrational modes have been assigned as intraligand vibrations that possess dominant quinoxaline character (1345 cm−1, red circles) and C=C + quinoxaline character (1551 cm−1, blue circles). (Inset) Electron density difference map that details the nature of the intraligand transition in 1 (red: electron density loss in transition, green: electron density gain in transition; H-atoms omitted for clarity).

Two key resonance structures can be drawn for the dithiolene ligand in 1 (Fig. 5). Structure A is a typical reduced dithiolene while B represents an induced internal redox reaction between the dithiolene and the quinoxaline components of the ligand. The admixture of resonance structure B into A is reflected in the nature of the dithiolene(S)→quinoxaline intraligand CT transition and is responsible for the Mo-S bond asymmetry found in the X-ray structure of 1. Together, these resonance forms underscore the remarkable non-innocence of this dithiolene ligand.

Figure 5.

Figure 5

Two contributing resonance structures for the S2BMOQO dithiolene ligand in 1. A: dithiol, B; thiol/thione.

Our results illustrate how an N-heterocycle containing dithiolene can stabilize the Mo(IV) oxidation state and dramatically modify the electronic structure of the oxomolybdenum-dithiolene unit. Dithiolene ligands have been shown to electronically buffer the metal center against large changes in charge that accompany redox processes, and it has been suggested that this is one of the fundamental roles of the pyranopterin dithiolene in catalysis.22 The S---S fold angles in 1 (14.5 and 12.0 °) are intermediate between those observed in Tp*MoO(qdt) (29.5°) and Tp*MoO(bdt) (21.3°), and in Tp*MoO(bdt-Cl2) (6.9°).20 The relatively large fold angle in 1 may result from the fact that the electron rich Mo(IV) center is coupled to a highly electron withdrawing dithiolene which can facilitate a backward Mo(xy)→dithiolene charge donation. This is consistent with the nature of the low energy CT transitions and the redox properties of 1. In summary, a rare thiolate-thione ligand in compound 1 exhibits highly versatile donor-acceptor character that affects the Mo(IV/V) redox couple and points to a potentially non-innocent role of the pterin-dithiolene in modulating pyranopterin molybdenum redox potentials during the course of catalysis.

Supplementary Material

Supporting Information

Acknowledgment

MLK acknowledges the NIH (GM-057378) and the NSF (NSF CHE-0616190) for financial assistance. SJNB acknowledges the NIH (GM081848). SJNB thanks Pat Carroll and the Facility for X-ray Crystallography in the Chemistry Department of the University of Pennsylvania

Footnotes

Supporting Information Available: Synthetic, spectroscopic, computational, full crystallographic details. EPR specrtrum of 3 and rR spectrum of 1 at 514nm. This material is available free of charge via the Internet at http://pubs.acs.org

References

  • 1.Kirk ML, Helton ME, McNaughton RL. Prog. Inorg. Chem. 2004;52:111–212. [Google Scholar]
  • 2.Stiefel EI. Pure Appl. Chem. 1998;70:889–896. [Google Scholar]
  • 3.Szilagyi RK, Lim BS, Glaser T, Holm RH, Hedman B, Hodgson KO, Solomon EI. J. Am. Chem. Soc. 2003;125:9158–9169. doi: 10.1021/ja029806k. [DOI] [PubMed] [Google Scholar]
  • 4.Sproules S, Benedito FL, Bill E, Weyhermuller T, George SD, Wieghardt K. Inorg. Chem. 2009;48:10926–10941. doi: 10.1021/ic9010532. [DOI] [PubMed] [Google Scholar]
  • 5.Depperman EC, Bodnar SH, Vostrikova KE, Shultz DA, Kirk ML. J. Am. Chem. Soc. 2001;123:3133. doi: 10.1021/ja003739h. [DOI] [PubMed] [Google Scholar]
  • 6.Kirk ML, Shultz DA, Depperman EC, Brannen CL. J. Am. Chem. Soc. 2007;129:1937–1943. doi: 10.1021/ja065384t. [DOI] [PubMed] [Google Scholar]
  • 7.Kirk ML, Shultz DA, Schmidt RD, Habel-Rodriguez D, Lee H, Lee J. J. Am. Chem. Soc. 2009;131:18304–18313. doi: 10.1021/ja904648r. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Burgmayer SJN. Dithiolenes in Biology. Vol. 52. Hoboken, New Jersey: John Wiley and Sons, Inc.; 2004. pp. 491–538. [Google Scholar]
  • 9.Stiefel EI. J. Chem. Soc., Dalton Trans. 1997:3915–3923. [Google Scholar]
  • 10.Weiss EA, Ahrens MJ, Sinks LE, Gusev AV, Ratner MA, Wasielewski MR. J. Am. Chem. Soc. 2004;126:5577. doi: 10.1021/ja0398215. [DOI] [PubMed] [Google Scholar]
  • 11.Aviram A, Ratner MA. Chem. Phys. Lett. 1974;29:277. [Google Scholar]
  • 12.Stokbro K, Taylor J, Brandbyge M. J. Am. Chem. Soc. 2003;125:3674–3675. doi: 10.1021/ja028229x. [DOI] [PubMed] [Google Scholar]
  • 13.Cummings SD, Eisenberg R. J. Am. Chem. Soc. 1996;118:1949–1960. [Google Scholar]
  • 14.Zuleta JA, Bevilacqua JM, Rehm JM, Eisenberg R. J. Am. Chem. Soc. 1992;31:1332–1337. [Google Scholar]
  • 15.Hille R. Chem. Rev. 1996;96:2757–2816. doi: 10.1021/cr950061t. [DOI] [PubMed] [Google Scholar]
  • 16.Hille R. Molybdenum enzymes containing the pyranopterin cofactor: An overview. Vol. 39. New York: Marcel Dekker, Inc.; 2002. pp. 187–226. [PubMed] [Google Scholar]
  • 17.Ray K, George SD, Solomon EI, Wieghardt K, Neese F. Chemistry-A European Journal. 2007;13:2783–2797. doi: 10.1002/chem.200601425. [DOI] [PubMed] [Google Scholar]
  • 18.Helton ME, Gebhart NL, Davies ES, McMaster J, Garner CD, Kirk ML. J. Am. Chem. Soc. 2001;123:10389. doi: 10.1021/ja0100470. [DOI] [PubMed] [Google Scholar]
  • 19.Burgmayer SJN, Kim M, Petit R, Rothkopf A, Kim A, BelHamdounia S, Hou Y, Somogyi A, Habel-Rodriguez D, Williams A, Kirk ML. J. Inorg. Biochem. 2007;101:1601–1616. doi: 10.1016/j.jinorgbio.2007.07.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Inscore FE, Knottenbelt SZ, Rubie ND, Joshi HK, Kirk ML, Enemark JH. Inorg. Chem. 2006;45:967. doi: 10.1021/ic0506815. [DOI] [PubMed] [Google Scholar]
  • 21.Inscore F, McNaughton R, Westcott B, Helton M, Jones R, Dhawan I, Enemark J, Kirk M. Inorg. Chem. 1999;38:1401–1410. [Google Scholar]
  • 22.Westcott BL, Gruhn NE, Enemark JH. J. Am. Chem. Soc. 1998;120:3382–3386. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES